- PRMT5 knockdown enhances cell viability and suppresses cell apoptosis, oxidative stress, inflammation and endothelial dysfunction in ox-LDL-induced vascular endothelial cells via interacting with PDCD4
Xiaohong Fei et al, 2023, International Immunopharmacology CrossRef - Development of selective class I protein arginine methyltransferase inhibitors through fragment-based drug design approach
Debomita Bhattacharya et al, 2023, European Journal of Medicinal Chemistry CrossRef - Overview of the development of protein arginine methyltransferase modulators: Achievements and future directions
Chao Tong et al, 2024, European Journal of Medicinal Chemistry CrossRef - Protein Arginine Methyltransferases: Emerging Targets in Cardiovascular and Metabolic Disease
Yan Zhang et al, 2024, Diabetes & Metabolism Journal CrossRef - PRMT1 in human neoplasm: cancer biology and potential therapeutic target
Shiquan Shen et al, 2024, Cell Communication and Signaling CrossRef - Role of protein arginine methyltransferase 1 in obesity‐related metabolic disorders: Research progress and implications
Xiaolei Xuan et al, 2024, Diabetes, Obesity and Metabolism CrossRef - Blood DNA methylation signature of diet quality and association with cardiometabolic traits
Jorge Domínguez-Barragán et al, 2024, European Journal of Preventive Cardiology CrossRef